Understanding how glutamylation affects brain and retinal cell health

DEFINING STRUCTURAL AND GENETIC REQUISITES OF GLUTAMYLATION IN POLARIZED CELLS

NIH-funded research Veterans Biomedical Research Institute · NIH-10479966

This study is looking at how a specific chemical change in proteins affects brain and eye cells, with the hope of finding new ways to understand and treat Alzheimer's disease, which could help patients in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Biomedical Research Institute NIH-funded
Lab location1 site (East Orange, United States)
Project IDNIH-10479966 on NIH RePORTER

What this research studies

This research investigates the role of glutamylation, a chemical modification of proteins, in specialized brain and retinal cells. Using advanced techniques like mass spectrometry, the study aims to uncover how glutamylation occurs in retinal photoreceptors and which enzymes are crucial for the development of hippocampal cells. By exploring these mechanisms, the research seeks to determine how changes in glutamylation levels may relate to neurodegenerative diseases, particularly Alzheimer's. Patients may benefit from insights that could lead to new biomarkers or therapeutic targets for Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with Alzheimer's disease or those at risk for developing neurodegenerative conditions.

Not a fit: Patients with non-neurodegenerative conditions or those without cognitive impairment may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to new ways to diagnose or treat Alzheimer's disease by identifying biomarkers related to glutamylation.

How similar studies have performed: While the specific focus on glutamylation in polarized cells is relatively novel, related research has shown promise in understanding post-translational modifications in neurodegenerative diseases.

Where this research is happening

East Orange, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's DiseaseAlzheimer diseaseAlzheimer syndromeAlzheimer's disease dementiaAlzheimers disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.